STOCK TITAN

Director Delaney granted BYSI stock options under 2017 plan

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

BeyondSpring Inc. director Brendan Delaney received a grant of stock options for 20,427 ordinary shares on April 1, 2026 as equity compensation. The options have an exercise price of $1.64 per share and expire on April 1, 2036. All options vest on April 1, 2027, subject to his continuous service with the company through that date.

Positive

  • None.

Negative

  • None.
Insider Delaney Brendan
Role Director
Type Security Shares Price Value
Grant/Award Stock Options (right to buy) 20,427 $0.00 --
Holdings After Transaction: Stock Options (right to buy) — 20,427 shares (Direct)
Footnotes (1)
  1. [object Object]
Stock options granted 20,427 options Grant on April 1, 2026 to director Brendan Delaney
Exercise price $1.64 per share Conversion or exercise price of granted options
Expiration date April 1, 2036 Options’ stated expiration date
Vesting date April 1, 2027 All options vest on this date, subject to continuous service
Shares underlying options 20,427 ordinary shares Each option relates to one ordinary share
Stock Options financial
"Reflects the grant of stock options to purchase ordinary shares of the Issuer"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
Ordinary Shares financial
"Reflects the grant of stock options to purchase ordinary shares of the Issuer"
Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.
2017 Omnibus Incentive Plan financial
"under the 2017 Omnibus Incentive Plan. All of the stock options will vest"
vesting financial
"All of the stock options will vest on April 1, 2027, subject to the Reporting Person's continuous service"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Delaney Brendan

(Last)(First)(Middle)
C/O BEYONDSPRING INC., 100 CAMPUS DRIVE
WEST SIDE, 4TH FLOOR, SUITE 410

(Street)
FLORHAM PARK NEW JERSEY 07932

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
BeyondSpring Inc. [ BYSI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Options (right to buy)$1.6404/01/2026A20,427 (1)04/01/2036Ordinary Shares20,427$0.0020,427D
Explanation of Responses:
1. Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. All of the stock options will vest on April 1, 2027, subject to the Reporting Person's continuous service with the Issuer through such date.
/s/ Brendan Delaney04/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did BeyondSpring (BYSI) director Brendan Delaney receive in this Form 4 filing?

Brendan Delaney received a grant of stock options covering 20,427 ordinary shares. These options were awarded as compensation and give him the right to buy BeyondSpring ordinary shares at a fixed exercise price if vesting and other conditions are satisfied.

What is the exercise price and expiration date of Brendan Delaney’s BYSI stock options?

The granted stock options have an exercise price of $1.64 per ordinary share and expire on April 1, 2036. This means Delaney can choose to buy shares at $1.64 any time after vesting and before the April 1, 2036 expiration.

When do Brendan Delaney’s BeyondSpring (BYSI) stock options vest?

All of Brendan Delaney’s 20,427 stock options vest on April 1, 2027. Vesting is conditioned on his continuous service with BeyondSpring through that date, so he must remain in service until then to fully benefit from the award.

How many BeyondSpring (BYSI) derivative securities does Brendan Delaney hold after this transaction?

Following this grant, Brendan Delaney holds 20,427 derivative securities in the form of stock options. These options each relate to one ordinary share, giving him potential future ownership if he exercises them after they vest and before expiration.

Is Brendan Delaney’s BYSI stock option grant a market purchase or sale of shares?

The transaction is a grant of stock options, not a market purchase or sale. Delaney did not buy or sell shares on the open market; he received options as compensation, with potential future share purchases at $1.64 if exercised after vesting.